Invitae (NYSE:NVTA) Earns Hold Rating from Analysts at StockNews.com

Stock analysts at StockNews.com started coverage on shares of Invitae (NYSE:NVTA – Get Free Report) in a research report issued on Sunday. The brokerage set a “hold” rating on the medical research company’s stock. Separately, The Goldman Sachs Group lowered their target price on Invitae from $1.00 to $0.50 and set a “sell” rating on […]

Related Keywords

Canada ,Blackrock ,Nova Scotia ,United States , ,Investment Management ,Invitae Company Profile ,Goldman Sachs Group ,Invitae Corporation ,Geode Capital Management ,Vanguard Group Inc ,Blackrock Inc ,Goldman Sachs Group Inc ,Get Free Report ,Capital Management ,Sachs Group ,Invitae Daily ,Invitae ,Nyse Nvta ,Nvta ,Medical ,Initiated Coverage ,Stocknews Com ,